Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03703349

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
St Joseph University, Beirut, Lebanon (from the registry)
Registry
  • NCT NCT03703349
Other papers using this trial's data
  • Preoperative oral magnesium loading to prevent postoperative atrial fibrillation following coronary surgery: a prospective randomized controlled trial European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022-10-04 DOI, PubMed 35451469

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Lebanon (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03703349. Randomized; quadruple masking; primary purpose prevention. Start 2018-11-24 (actual); primary completion 2019-10-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)
Acronym
POMAF-CS
Condition
Surgery--Complications
Intervention (Drug)
Magnesium Sulfate
Intervention (Drug)
Placebo Oral Tablet
Lead sponsor
St Joseph University, Beirut, Lebanon (class: other)

Record details

Record id
cardio:ct-nct03703349
Content hash
e2787cad375cdba8764fa7c7c1da180957d32a225f24fdfb4dbd30106d970068